2026 Midwest Radiation Oncology Symposium

Friday–Saturday, Aug. 21-22, 2026

Friday: 7:15 a.m. – 4:45 p.m. US CDT
View Day 1 Agenda

Saturday: 7:15 a.m. – 4:20 p.m. US CDT
View Day 2 Agenda

Time Zone Converter

Attendance Options:

In-Person Location

Fred & Pamela Buffett Cancer Center – Rm 0.12.101
505 S 45th Street, Omaha, NE 68105

Virtual Attendance

Available via Zoom livestream
Instructions on how to join the livestream will be sent to registered participants via email a few days before the start of the symposium.

Cancer care is entering a new era defined by rapid advances in biology, technology, and multidisciplinary treatment approaches. As therapeutic options expand, clinical decision-making has become increasingly complex, requiring an integrated and patient-centered approach.

This symposium brings together key developments in tumor biology, contemporary clinical management, and innovations in radiation oncology to provide a cohesive framework for learning and discussion. Participants will explore how emerging insights into treatment response and resistance are shaping care, how multidisciplinary strategies are evolving across challenging disease sites, and how technologies such as adaptive radiotherapy, digital modeling, and artificial intelligence are influencing workflow and personalization.

By linking science, clinical evidence, and technology, this symposium aims to strengthen participants’ ability to optimize treatment selection, reduce toxicity, and improve patient outcomes and quality of life.

At the conclusion of this activity, the participants should be better able to:

Explain key advances in cancer biology relevant to radiation oncology, including DNA repair mechanisms, PR55α/PP2A signaling, mucin-mediated resistance, and the role of radioprotectors and radiosensitizers in modulating treatment response.
Evaluate multidisciplinary management strategies for complex malignancies, including locally advanced non-small cell lung cancer, gynecologic cancers, genitourinary cancers, and cutaneous non-melanoma skin cancers, and apply evidence-based approaches to clinical decision-making.
Integrate patient-centered care principles into oncology practice, including shared decision-making, patient education (including video and AI-assisted tools), and individualized treatment planning in complex clinical scenarios.
Assess emerging technological innovations in radiation oncology, including Digital Twin modeling, upright radiotherapy, adaptive radiotherapy, and AI/LLM-based clinical tools, and determine their potential impact on workflow, personalization, and patient outcomes.
Synthesize advances in biology, clinical oncology, and technology to optimize personalized cancer care, balancing tumor control, toxicity mitigation, and quality of life across diverse patient populations.

In support of improving patient care, University of Nebraska Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians

The University of Nebraska Medical Center designates this live activity for a maximum of 15.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses

The University of Nebraska Medical Center designates this activity for up to 15.0 ANCC contact hours. Nurses should only claim credit for the actual time spent participating in the activity.

Medical Physicists
This activity has been submitted to Commission on Accreditation of Medical Physics Education Program (CAMPEP) for approval of MPCEC hours.

Radiation Therapists
Category A/A+ CE credit is pending approval by the American Society of Radiologic Technologists (ASRT).

Dosimetrists
This activity has been submitted to the Medical Dosimetrist Certification Board (MDCB) for continuing education credit approval.

Registration Information

Early Registration

Available through July 24

Day 1 (Aug. 21 only): $65
Day 2 (Aug. 22 only): $65
Full Symposium (Aug. 21–22): $100

Regular Registration

Beginning July 25

Day 1 (Aug. 21 only): $100
Day 2 (Aug. 22 only): $100
Full Symposium (Aug. 21–22): $150

Fellows/Residents/Students

Fellows, residents, and students may attend this symposium for free.

The deadline to register is Aug. 14, 2026.

Payment Options

Credit/Debit Card: Credit and debit card payments are accepted. A non-refundable processing fee will be added to all credit/debit card transactions: $3 for registrations of $65 or $100, and 2.95% for registrations of $150.
E-Check/ACH Transfer: Electronic check (ACH) payments are strongly recommended and do not incur any additional fees.

If you need assistance with online registration, please call our Registration Office at 402-559-5929.

Cancellation and Refund Policy

If you need to cancel your registration, please email registrationCCE@unmc.edu no later than Aug. 14, 2026. A $25 processing fee will apply to cancellations received by this date. Please note that if you paid by credit or debit card, the card processing fee is non-refundable. Cancellations made after Aug. 14, as well as registrants who do not attend, are responsible for the full registration fee.

Symposium Director

Chi Lin, MD, PhD

Professor and Vice Chair of Research, Department of Radiation Oncology, UNMC

Questions?

Missy Edwards

Educational Projects Coordinator

Center for Continuing Education, UNMC

Send Email

Phone: 402-559-5145